Epidiolex (cannabidiol) prior authorization denied appeal
CBD for Lennox-Gastaut, Dravet, TSC-associated seizures
Typical PA criteria
- Lennox-Gastaut, Dravet, or TSC-associated seizures with ICD-10
- Prior AED trial (typically ≥2 concurrent AEDs)
- Neurology prescriber
- LFT monitoring plan (hepatotoxicity risk)
Why your PA was denied
- Prior AED trial insufficient
- Non-neurology prescriber
- Off-label seizure type
- LFT baseline missing
Evidence that overturns the denial
- ✓Seizure frequency baseline
- ✓AED trial documentation with dates, doses, outcomes
- ✓Neurology letter
- ✓Baseline LFTs
Only FDA-approved CBD product; off-label epilepsy uses are consistently denied. Neurology-only prescribing on most formularies.
Free analysis identifies the cited policy and missing evidence. Then a finished letter that maps your chart to the criteria.
FAQ
Why was my Epidiolex (cannabidiol) prior authorization denied?+
The most common reasons are: Prior AED trial insufficient; Non-neurology prescriber; Off-label seizure type. Your denial letter names the specific criteria you did not meet.
How do I appeal a Epidiolex (cannabidiol) denial?+
File a written appeal within 180 days that cites the insurer's clinical policy, includes a letter of medical necessity from the prescriber, and documents the criteria the insurer requires.
What evidence overturns a Epidiolex (cannabidiol) denial?+
Seizure frequency baseline; AED trial documentation with dates, doses, outcomes; Neurology letter.
What if the plan excludes Epidiolex (cannabidiol) entirely?+
Plan exclusions are different from medical-necessity denials. Check the Summary Plan Description. If the drug is fully excluded, an appeal will not overturn it; you may need a formulary exception or manufacturer assistance program.
Other drugs
- Wegovy (semaglutide)
- Zepbound (tirzepatide)
- Ozempic (semaglutide)
- Mounjaro (tirzepatide)
- Saxenda (liraglutide)